Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?

Détails

ID Serval
serval:BIB_A98AC09F5BDF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?
Périodique
Clinical Nuclear Medicine
Auteur(s)
Lhommel R., Sempoux C., Ivanoiu A., Michaux L., Gerber B.
ISSN
1536-0229 (Electronic)
ISSN-L
0363-9762
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
39
Numéro
8
Pages
747-749
Langue
anglais
Notes
Publication types: Journal Article Publication Status: ppublish
Résumé
We report here the case of a 56-year-old man with well-documented cardiac light chain amyloidosis successfully imaged with F-flutemetamol PET/CT in 2011. A matched pair healthy volunteer was imaged in the same conditions, and no specific heart uptake could be detected. The present report suggests the potential benefit of this new pharmaceutical in this indication, as it has been recently reported for C-Pittsburgh compound B, but with the main advantage to benefit from the more practical half-life of F. Further prospective trials would, however, be required to define the potential impact of F-flutemetamol PET/CT in cardiac amyloidosis.
Pubmed
Web of science
Création de la notice
16/01/2015 13:11
Dernière modification de la notice
20/08/2019 16:13
Données d'usage